Gerić, Tamara

Link to this page

Authority KeyName Variants
fd0a7990-098e-40c8-97f6-e68dcbe8b4e3
  • Gerić, Tamara (3)
Projects

Author's Bibliography

Sinteza lutecijuma(III) kompleksa sa poliazamakrocikličnim ligandom

Stanić, Vojislav; Tanasković, Slađana; Jelić, Ivana; Janković, Marija; Jovanović, Dragoljub; Gerić, Tamara; Nastasijević, Branislav

(Beograd : Univerzitet u Beogradu, Institut za nuklearne nauke "Vinča", 2023)

TY  - CONF
AU  - Stanić, Vojislav
AU  - Tanasković, Slađana
AU  - Jelić, Ivana
AU  - Janković, Marija
AU  - Jovanović, Dragoljub
AU  - Gerić, Tamara
AU  - Nastasijević, Branislav
PY  - 2023
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12188
AB  - Radijacionо zračenje predstavlja specifičan način onkološkog lečenja, kod kojeg se antitumorski efekat postiže dejstvom jonizujućeg zračenja.Visokoenergetsko jonizujuće zračenje oštećuje genetski materijal ćelija tumorskog tkiva i tako ograničava ili onemogućuje njihovu sposobnost daljnjeg deljenja. Radioizotopi koji se koriste u lečenju u većini slučajeva grenerišu beta zračenje koje izaziva uništenje obolelih ćelija. Interesovanje za razvoj 177Lu kao radiofarmaceutika može se pripisati podobnosti njegovih nuklearnih svojstava za terapeutsku upotrebu, emisija β(-) i γ zračenja i njegovo dobro kompleksiranje sa raznim ligandima. U ovom radu je prikazana preliminarna sinteza kompleksa Lu(III) sa poliazamakrocikličnim ligandom.
AB  - Radiation is a specific method of oncological treatment, in which the action of ionizing radiation achieves the antitumor effect. High-energy ionizing radiation damages the genetic material of tumor tissue cells and thus limits or disables their ability to divide further. Radioisotopes used in treatment in most cases generate beta radiation that causes the destruction of diseased cells. The interest in developing 177Lu as a radiopharmaceutical can be attributed to the suitability of its nuclear properties for therapeutic use, the emission ofβ(-) and γ radiation, and its good complexation with various ligands. This paper presents the preliminary synthesis of Lu(III) complex with a polyazamacrocyclic ligand.
PB  - Beograd : Univerzitet u Beogradu, Institut za nuklearne nauke "Vinča"
PB  - Društvo za zaštitu od zračenja Srbije i Crne Gore
C3  - 32. simpozijum DZZSCG : zbornik radova
T1  - Sinteza lutecijuma(III) kompleksa sa poliazamakrocikličnim ligandom
T1  - Synthesis of Lutetium(III) Complex With a Polyazamacrocyclic Ligand
SP  - 395
EP  - 400
UR  - https://hdl.handle.net/21.15107/rcub_vinar_12188
ER  - 
@conference{
author = "Stanić, Vojislav and Tanasković, Slađana and Jelić, Ivana and Janković, Marija and Jovanović, Dragoljub and Gerić, Tamara and Nastasijević, Branislav",
year = "2023",
abstract = "Radijacionо zračenje predstavlja specifičan način onkološkog lečenja, kod kojeg se antitumorski efekat postiže dejstvom jonizujućeg zračenja.Visokoenergetsko jonizujuće zračenje oštećuje genetski materijal ćelija tumorskog tkiva i tako ograničava ili onemogućuje njihovu sposobnost daljnjeg deljenja. Radioizotopi koji se koriste u lečenju u većini slučajeva grenerišu beta zračenje koje izaziva uništenje obolelih ćelija. Interesovanje za razvoj 177Lu kao radiofarmaceutika može se pripisati podobnosti njegovih nuklearnih svojstava za terapeutsku upotrebu, emisija β(-) i γ zračenja i njegovo dobro kompleksiranje sa raznim ligandima. U ovom radu je prikazana preliminarna sinteza kompleksa Lu(III) sa poliazamakrocikličnim ligandom., Radiation is a specific method of oncological treatment, in which the action of ionizing radiation achieves the antitumor effect. High-energy ionizing radiation damages the genetic material of tumor tissue cells and thus limits or disables their ability to divide further. Radioisotopes used in treatment in most cases generate beta radiation that causes the destruction of diseased cells. The interest in developing 177Lu as a radiopharmaceutical can be attributed to the suitability of its nuclear properties for therapeutic use, the emission ofβ(-) and γ radiation, and its good complexation with various ligands. This paper presents the preliminary synthesis of Lu(III) complex with a polyazamacrocyclic ligand.",
publisher = "Beograd : Univerzitet u Beogradu, Institut za nuklearne nauke "Vinča", Društvo za zaštitu od zračenja Srbije i Crne Gore",
journal = "32. simpozijum DZZSCG : zbornik radova",
title = "Sinteza lutecijuma(III) kompleksa sa poliazamakrocikličnim ligandom, Synthesis of Lutetium(III) Complex With a Polyazamacrocyclic Ligand",
pages = "395-400",
url = "https://hdl.handle.net/21.15107/rcub_vinar_12188"
}
Stanić, V., Tanasković, S., Jelić, I., Janković, M., Jovanović, D., Gerić, T.,& Nastasijević, B.. (2023). Sinteza lutecijuma(III) kompleksa sa poliazamakrocikličnim ligandom. in 32. simpozijum DZZSCG : zbornik radova
Beograd : Univerzitet u Beogradu, Institut za nuklearne nauke "Vinča"., 395-400.
https://hdl.handle.net/21.15107/rcub_vinar_12188
Stanić V, Tanasković S, Jelić I, Janković M, Jovanović D, Gerić T, Nastasijević B. Sinteza lutecijuma(III) kompleksa sa poliazamakrocikličnim ligandom. in 32. simpozijum DZZSCG : zbornik radova. 2023;:395-400.
https://hdl.handle.net/21.15107/rcub_vinar_12188 .
Stanić, Vojislav, Tanasković, Slađana, Jelić, Ivana, Janković, Marija, Jovanović, Dragoljub, Gerić, Tamara, Nastasijević, Branislav, "Sinteza lutecijuma(III) kompleksa sa poliazamakrocikličnim ligandom" in 32. simpozijum DZZSCG : zbornik radova (2023):395-400,
https://hdl.handle.net/21.15107/rcub_vinar_12188 .

Synthesis and characterization of luminescent Pr3+ –doped hydroxyapatite nanopowder as a potential biomaterial for bioimaging applications

Stanić, Vojislav; Omerašević, Mia; Mutavdžić, Dragoslav; Jugović, Dragana; Bučevac, Dušan; Gerić, Tamara; Jelić, Ivana

(Belgrade : Serbian Ceramic Society, 2023)

TY  - CONF
AU  - Stanić, Vojislav
AU  - Omerašević, Mia
AU  - Mutavdžić, Dragoslav
AU  - Jugović, Dragana
AU  - Bučevac, Dušan
AU  - Gerić, Tamara
AU  - Jelić, Ivana
PY  - 2023
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/11647
AB  - Praseodymium doped calcium hydroxyapatite (PrHAP) nanopowder was synthesized by the co-precipitation method and characterized by X-Ray Diffraction, Fourier Transform Infrared, and Fluorescence Spectroscopy. Characterization studies from XRD and FTIR spectra showed that obtained crystals are monophase hydroxyapatites and that the sample particles are of nano size. A fluorescence study has shown that PrHAP particles have fluorescent emission under UV‐ Visible excitation. These results may open new avenues for developing bioactive materials for bone regeneration and fluorescent probes for bio-imaging applications
PB  - Belgrade : Serbian Ceramic Society
C3  - Advanced Ceramics and Application :11th Serbian Ceramic Society Conference : program and the book of abstracts; September 18-20, 2023; Belgrade
T1  - Synthesis and characterization of luminescent Pr3+ –doped hydroxyapatite nanopowder as a potential biomaterial for bioimaging applications
SP  - 72
UR  - https://hdl.handle.net/21.15107/rcub_vinar_11647
ER  - 
@conference{
author = "Stanić, Vojislav and Omerašević, Mia and Mutavdžić, Dragoslav and Jugović, Dragana and Bučevac, Dušan and Gerić, Tamara and Jelić, Ivana",
year = "2023",
abstract = "Praseodymium doped calcium hydroxyapatite (PrHAP) nanopowder was synthesized by the co-precipitation method and characterized by X-Ray Diffraction, Fourier Transform Infrared, and Fluorescence Spectroscopy. Characterization studies from XRD and FTIR spectra showed that obtained crystals are monophase hydroxyapatites and that the sample particles are of nano size. A fluorescence study has shown that PrHAP particles have fluorescent emission under UV‐ Visible excitation. These results may open new avenues for developing bioactive materials for bone regeneration and fluorescent probes for bio-imaging applications",
publisher = "Belgrade : Serbian Ceramic Society",
journal = "Advanced Ceramics and Application :11th Serbian Ceramic Society Conference : program and the book of abstracts; September 18-20, 2023; Belgrade",
title = "Synthesis and characterization of luminescent Pr3+ –doped hydroxyapatite nanopowder as a potential biomaterial for bioimaging applications",
pages = "72",
url = "https://hdl.handle.net/21.15107/rcub_vinar_11647"
}
Stanić, V., Omerašević, M., Mutavdžić, D., Jugović, D., Bučevac, D., Gerić, T.,& Jelić, I.. (2023). Synthesis and characterization of luminescent Pr3+ –doped hydroxyapatite nanopowder as a potential biomaterial for bioimaging applications. in Advanced Ceramics and Application :11th Serbian Ceramic Society Conference : program and the book of abstracts; September 18-20, 2023; Belgrade
Belgrade : Serbian Ceramic Society., 72.
https://hdl.handle.net/21.15107/rcub_vinar_11647
Stanić V, Omerašević M, Mutavdžić D, Jugović D, Bučevac D, Gerić T, Jelić I. Synthesis and characterization of luminescent Pr3+ –doped hydroxyapatite nanopowder as a potential biomaterial for bioimaging applications. in Advanced Ceramics and Application :11th Serbian Ceramic Society Conference : program and the book of abstracts; September 18-20, 2023; Belgrade. 2023;:72.
https://hdl.handle.net/21.15107/rcub_vinar_11647 .
Stanić, Vojislav, Omerašević, Mia, Mutavdžić, Dragoslav, Jugović, Dragana, Bučevac, Dušan, Gerić, Tamara, Jelić, Ivana, "Synthesis and characterization of luminescent Pr3+ –doped hydroxyapatite nanopowder as a potential biomaterial for bioimaging applications" in Advanced Ceramics and Application :11th Serbian Ceramic Society Conference : program and the book of abstracts; September 18-20, 2023; Belgrade (2023):72,
https://hdl.handle.net/21.15107/rcub_vinar_11647 .

The Effect of Honey on Malondialdehyde Level in Plasma Exposed to a Therapeutic Dose of Radiation

Stanić, Vojislav; Gavrilović, Ljubica; Stojiljković, Vesna; Karakašević, Aleksandar; Pantelić, Marija; Gerić, Tamara; Stanković, Srboljub

(Beograd : Univerzitet u Beogradu, Institut za nuklearne nauke "Vinča", 2023)

TY  - CONF
AU  - Stanić, Vojislav
AU  - Gavrilović, Ljubica
AU  - Stojiljković, Vesna
AU  - Karakašević, Aleksandar
AU  - Pantelić, Marija
AU  - Gerić, Tamara
AU  - Stanković, Srboljub
PY  - 2023
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12189
AB  - Malondialdehyde (MDA) is the end product of lipid peroxidation and biomarker of free radicals. The aim of this study is to investigate the effect of honey on concentrations of MDA in plasma exposed to a therapeutic dose of radiation. In this experiment animals were divided into two groups: in CONTROL group the animals were given distilled water orally for 28 days, and HONEY group consisted of animals given 1,5 ml/kg honey orally for 28 days. Blood samples of both groups were collected from a rat's tail. All blood samples were exposed to radiation of 2 Gy. Malondialdehyde concentration in plasma was determined using spectrophotometric method. Honey treatment in the blood plasma exposed to a therapeutic dose of 2 Gy significantly decreased MDA level by 30 % compared with control group. The present results indicated that honey had an effect on the levels of MDA in plasma exposed to radiation.
AB  - Malondialdehid (MDA) je krajnji proizvod peroksidacije lipida i biomarker slobodnih radikala. Cilj ovog istraživanja je bio da se ispita uticaj meda na koncentraciju MDA u krvnoj plazmi izloženoj terapijskoj dozi zračenja. U ovom eksperimentu životinje su podeljene u dve grupe: u kontrolnoj grupi životinje su dobijale destilovanu vodu oralno tokom 28 dana, a drugu grupu činile su životinje koje su tokom 28 dana dobijale oralno 1.5 ml/kg meda. Uzorci krvi obe grupe su sakupljeni iz repa pacova. Svi uzorci krvi bili su izloženi zračenju od 2 Gy. Koncentracija MDA u plazmi određena je spektrofotometrijskom metodom. Tretman medom u krvnoj plazmi izložen terapijskoj dozi od 2 Gy značajno je smanjio nivo MDA (30 %) u poređenju sa kontrolnom grupom.
PB  - Beograd : Univerzitet u Beogradu, Institut za nuklearne nauke "Vinča"
PB  - Društvo za zaštitu od zračenja Srbije i Crne Gore
C3  - 32. simpozijum DZZSCG : zbornik radova
T1  - The Effect of Honey on Malondialdehyde Level in Plasma Exposed to a Therapeutic Dose of Radiation
T1  - Delovanje meda na nivo malondialdehida u plazmi izloženoj terapijskoj dozi zračenja
SP  - 417
EP  - 423
UR  - https://hdl.handle.net/21.15107/rcub_vinar_12189
ER  - 
@conference{
author = "Stanić, Vojislav and Gavrilović, Ljubica and Stojiljković, Vesna and Karakašević, Aleksandar and Pantelić, Marija and Gerić, Tamara and Stanković, Srboljub",
year = "2023",
abstract = "Malondialdehyde (MDA) is the end product of lipid peroxidation and biomarker of free radicals. The aim of this study is to investigate the effect of honey on concentrations of MDA in plasma exposed to a therapeutic dose of radiation. In this experiment animals were divided into two groups: in CONTROL group the animals were given distilled water orally for 28 days, and HONEY group consisted of animals given 1,5 ml/kg honey orally for 28 days. Blood samples of both groups were collected from a rat's tail. All blood samples were exposed to radiation of 2 Gy. Malondialdehyde concentration in plasma was determined using spectrophotometric method. Honey treatment in the blood plasma exposed to a therapeutic dose of 2 Gy significantly decreased MDA level by 30 % compared with control group. The present results indicated that honey had an effect on the levels of MDA in plasma exposed to radiation., Malondialdehid (MDA) je krajnji proizvod peroksidacije lipida i biomarker slobodnih radikala. Cilj ovog istraživanja je bio da se ispita uticaj meda na koncentraciju MDA u krvnoj plazmi izloženoj terapijskoj dozi zračenja. U ovom eksperimentu životinje su podeljene u dve grupe: u kontrolnoj grupi životinje su dobijale destilovanu vodu oralno tokom 28 dana, a drugu grupu činile su životinje koje su tokom 28 dana dobijale oralno 1.5 ml/kg meda. Uzorci krvi obe grupe su sakupljeni iz repa pacova. Svi uzorci krvi bili su izloženi zračenju od 2 Gy. Koncentracija MDA u plazmi određena je spektrofotometrijskom metodom. Tretman medom u krvnoj plazmi izložen terapijskoj dozi od 2 Gy značajno je smanjio nivo MDA (30 %) u poređenju sa kontrolnom grupom.",
publisher = "Beograd : Univerzitet u Beogradu, Institut za nuklearne nauke "Vinča", Društvo za zaštitu od zračenja Srbije i Crne Gore",
journal = "32. simpozijum DZZSCG : zbornik radova",
title = "The Effect of Honey on Malondialdehyde Level in Plasma Exposed to a Therapeutic Dose of Radiation, Delovanje meda na nivo malondialdehida u plazmi izloženoj terapijskoj dozi zračenja",
pages = "417-423",
url = "https://hdl.handle.net/21.15107/rcub_vinar_12189"
}
Stanić, V., Gavrilović, L., Stojiljković, V., Karakašević, A., Pantelić, M., Gerić, T.,& Stanković, S.. (2023). The Effect of Honey on Malondialdehyde Level in Plasma Exposed to a Therapeutic Dose of Radiation. in 32. simpozijum DZZSCG : zbornik radova
Beograd : Univerzitet u Beogradu, Institut za nuklearne nauke "Vinča"., 417-423.
https://hdl.handle.net/21.15107/rcub_vinar_12189
Stanić V, Gavrilović L, Stojiljković V, Karakašević A, Pantelić M, Gerić T, Stanković S. The Effect of Honey on Malondialdehyde Level in Plasma Exposed to a Therapeutic Dose of Radiation. in 32. simpozijum DZZSCG : zbornik radova. 2023;:417-423.
https://hdl.handle.net/21.15107/rcub_vinar_12189 .
Stanić, Vojislav, Gavrilović, Ljubica, Stojiljković, Vesna, Karakašević, Aleksandar, Pantelić, Marija, Gerić, Tamara, Stanković, Srboljub, "The Effect of Honey on Malondialdehyde Level in Plasma Exposed to a Therapeutic Dose of Radiation" in 32. simpozijum DZZSCG : zbornik radova (2023):417-423,
https://hdl.handle.net/21.15107/rcub_vinar_12189 .